96 related articles for article (PubMed ID: 6892202)
1. Cytostatic activity in vitro of new cis-dichlorodiammineplatinum (II) analogs.
Duś D; Kuduk-Jaworska J
Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):357-61. PubMed ID: 6892202
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of pre-mRNA splicing by cisplatin and platinum analogs.
Schmittgen TD; Ju JF; Danenberg KD; Danenberg PV
Int J Oncol; 2003 Sep; 23(3):785-9. PubMed ID: 12888918
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy in vitro with cis-dichlorodiammineplatinum(II).
Drewinko B; Green C; Loo TL
Cancer Treat Rep; 1976 Nov; 60(11):1619-25. PubMed ID: 1021234
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anticancer activity of new 1-substituted-6H-pyrido[4,3-b]carbazole derivatives.
Tylińska B; Jasztold-Howorko R; Mastalarz H; Szczaurska-Nowak K; Wietrzyk J
Arch Pharm (Weinheim); 2008 Jun; 341(6):351-6. PubMed ID: 18404778
[TBL] [Abstract][Full Text] [Related]
5. Cytostatic activity in vitro of phosphonic acid derivatives.
Duś D; Wojdat E; Radzikowski C; Mastalerz P
Arch Immunol Ther Exp (Warsz); 1985; 33(2):325-9. PubMed ID: 4084009
[TBL] [Abstract][Full Text] [Related]
6. Effects of cis-dichlorodiammineplatinum(II) on human colon carcinoma cells in vitro.
Bergerat JP; Barlogie B; Drewinko B
Cancer Res; 1979 Apr; 39(4):1334-8. PubMed ID: 421217
[TBL] [Abstract][Full Text] [Related]
7. In vitro effect of Pt and Pd mercaptopyridine complexes.
Carrara M; Berti T; D'Ancona S; Cherchi V; Sindellari L
Anticancer Res; 1997; 17(2A):975-80. PubMed ID: 9137437
[TBL] [Abstract][Full Text] [Related]
8. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
Schmidt W; Chaney SG
Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
[TBL] [Abstract][Full Text] [Related]
9. Combination effects of cis-dichlorodiammineplatinum with selected metahalones, pyrimidine sulfoxides and pyrimidine sulfones on human NHIK 3025 cells in vitro.
Dornish JM; Undheim K; Pettersen EO; Oftebro R; Laland SG
Anticancer Drug Des; 1988 Dec; 3(3):191-8. PubMed ID: 3207466
[TBL] [Abstract][Full Text] [Related]
10. Effect of cis- and trans-dichlorodiammineplatinum(II) on human tumor cell proliferation in diffusion chambers in vivo.
Ambrose KR; Lowrey JS
Cancer Res; 1982 May; 42(5):1769-73. PubMed ID: 7039818
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activity of a new mixed-ligand complex di-n-butyl-(4-chlorobenzohydroxamato)tin(IV) chloride.
Li Y; Li Y; Niu X; Jie L; Shang X; Guo J; Li Q
J Inorg Biochem; 2008 Sep; 102(9):1731-5. PubMed ID: 18573534
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.
Samimi G; Howell SB
Cancer Chemother Pharmacol; 2006 Jun; 57(6):781-8. PubMed ID: 16170571
[TBL] [Abstract][Full Text] [Related]
14. The effect of cis-DDP and Pt mercaptopyridine complexes on cell lines in vitro.
Mazzo M; Cherchi V; Nicolini M; Sindellari L; Sitran S; Manchiaro P; D'Ancona S; Berti T
Farmaco; 1993 Dec; 48(12):1631-40. PubMed ID: 8135987
[TBL] [Abstract][Full Text] [Related]
15. Toxic variability and radiation sensitization by dichlorodiammineplatinum(II) complexes in Salmonella typhimurium cells.
Richmond RC
Radiat Res; 1984 Sep; 99(3):596-608. PubMed ID: 6382408
[TBL] [Abstract][Full Text] [Related]
16. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
Kido Y; Khokhar AR; al-Baker S; Siddik ZH
Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato) titanium(IV) compounds against Walker 256 carcinosarcoma. A new class of antineoplastic agents.
Keller HJ; Keppler B; Schmähl D
Arzneimittelforschung; 1982; 32(8):806-7. PubMed ID: 6890355
[TBL] [Abstract][Full Text] [Related]
18. The effect of cis-dichlorodiammineplatinum (II) and Acronycin on the proliferation and respiration of HeLa cells in vitro.
Kovarík J; Svec F; Thurzo V
Neoplasma; 1972; 19(6):569-77. PubMed ID: 4670379
[No Abstract] [Full Text] [Related]
19. Increased expression of thioredoxin/adult T-cell leukemia-derived factor in cisplatin-resistant human cancer cell lines.
Yamada M; Tomida A; Yoshikawa H; Taketani Y; Tsuruo T
Clin Cancer Res; 1996 Feb; 2(2):427-32. PubMed ID: 9816187
[TBL] [Abstract][Full Text] [Related]
20. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH
Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
